IMMUNE-RELATED ADVERSE EVENTS

Clinical trials for IMMUNE-RELATED ADVERSE EVENTS explained in plain language.

Never miss a new study

Get alerted when new IMMUNE-RELATED ADVERSE EVENTS trials appear

Sign up with your email to follow new studies for IMMUNE-RELATED ADVERSE EVENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet finished but already full! 1

New hope to tame dangerous side effects of powerful cancer drugs

Symptom relief Ongoing

This study is testing two drugs, rituximab or tocilizumab, to help people with advanced cancer who develop severe, long-lasting side effects from their immunotherapy treatment. These side effects often require patients to take high doses of steroids, which can cause serious healt…

Matched conditions: IMMUNE-RELATED ADVERSE EVENTS

Phase: PHASE2 • Sponsor: Columbia University • Aim: Symptom relief

Last updated Mar 17, 2026 12:55 UTC

IMMUNE-RELATED ADVERSE EVENTS

Get alerted when new IMMUNE-RELATED ADVERSE EVENTS trials appear

New hope to tame dangerous side effects of powerful cancer drugs